VLX-1005

· Veralox Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLX-1005, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia [Phase 2]